The Medicines Control Council has withdrawn the diabetes medicine Avandia from the market because it contains a substance that might increase the likelihood of a heart attack.
The medication, produced by GlaxoSmithKline, is prescribed to some type2 diabetics.
The council made the decision five weeks ago “due to safety risks” attributed to rosiglitazone, a constituent of Avandia.
A statement by the council on Tuesday said: “Rosiglitazone is associated with an increased risk [of] heart failure, myocardial infarction [heart attack] and cardiac arrest”.
Read the full article on ~uTimeslive.co.za#www.timeslive.co.za/news/2011/07/06/council-withdraws-diabetes-medicine~